Singapore: Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetic...
Singapore: Singapore Eye Research Institute (SERI) and Bayer HealthCare are urging on earlier diagnosis and treatment of...
Singapore: Scientists from A*STAR's Singapore Institute for Clinical Sciences (SICS), together with clinical collaborat...
Singapore: The Institute of Chemical and Engineering Sciences (ICES), a research institute of the Agency for Science, T...
The medical devices industry has progressed by leaps and bounds in the recent past and this is evident from the several ...
Singapore: Vietnam Ministry of Health's Administration of Science, Technology and Training (ASTT) has signed an agreemen...
Singapore: International and regional healthcare experts at the 2013 Asia PDC have urged the public to make the fight ag...
Recently, Health Sciences Authority (HSA) of Singapore enhanced its regulatory framework for low-risk Class A and B medi...
Singapore: Singapore based SFS Pharma Logistics registered its first success in global supply chain management platform ...
Singapore: AstraZeneca has launched Brilinta (ticagrelor) for the prevention of atherothrombotic events in adult patient...
We come across several women in the field of biotechnology at the graduation and post-graduation level of education. How...
Singapore: Singapore-based WEB Biotechnology, developer of the world's first cloud-based continuous ECG monitor called S...
Singapore: A*STAR scientists from the Institute of Molecular and Cell Biology (IMCB) have solved the problem of how Cand...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Israel-based ARGO Medical Technologies has partnered with innovative robotics experts Yaskawa Electric, Japan...
Singapore: A new report, launched by the International Osteoporosis Foundation (IOF), shows that osteoporosis is a loomi...
Singapore: For the first time in Singapore, a new oral treatment is available to advanced stage prostate cancer patients...
Singapore: Singapore-based TauRx Pharmaceuticals has received equity investment of $31.5 million from Genting Management...
